Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition

Journal of Clinical Pathology

Volumn 64, Issue 4, 2011, Pages 325-329

  Liu, Zhiyan ^a,b   Kakudo, Kennichi ^a   Bai, Yanhua ^a   Li, Yaqiong ^a   Ozaki, Takashi ^a   Miyauchi, Akira ^c   Taniguchi, Emiko ^a   Mori, Ichiro ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c KUMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; THYROID TRANSCRIPTION FACTOR 1; UVOMORULIN; VIMENTIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CELL ADHESION; CELL POLARITY; CELLULAR PARAMETERS; CLINICAL INDICATOR; CONTROLLED STUDY; DISEASE ASSOCIATION; ECTOPIC THYROID GLAND; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOSS OF CELLULAR POLARITY COHESIVENESS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; PAPILLARY THYROID CARCINOMA; PRIORITY JOURNAL; RECURRENCE RISK; THYROID CARCINOMA; THYROIDECTOMY; TUMOR RECURRENCE;

ADULT; AGED; BETA CATENIN; CADHERINS; CARCINOMA, PAPILLARY; CELL POLARITY; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; THYROID NEOPLASMS; TRANSCRIPTION FACTORS; VIMENTIN;

EID: 79953123495     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.083956     Document Type: Article

References (28)

1. Ostrowski ML, Merino MJ. Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol 1996;20:964-74. (Pubitemid 26250636)
2. Pilotti S, Collini P, Sampietro G, et al. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases. Cancer 1998;83:2421-3. (Pubitemid 28533514)
3. Ain KB. Papillary thyroid carcinoma. Etiology, assessment, and therapy. Endocrinol Metab Clin North Am 1995;24:711-60.
4. Moreno Egea A, Rodriguez Gonzalez JM, Sola Perez J, et al. Prognostic value of the tall cell variety of papillary cancer of the thyroid. Eur J Surg Oncol 1993;19:517-21. (Pubitemid 24024595)
5. Sywak M, Pasieka JL, Ogilvie T. A review of thyroid cancer with intermediate differentiation. J Surg Oncol 2004;86:44-54. (Pubitemid 38490100)
6. Bai Y, Kakudo K, Li Y, et al. Subclassification of non-solid-type papillary thyroid carcinoma identification of high-risk group in common type. Cancer Sci 2008;99:1908-15.
7. DeLellis RA. Lloyd RVHPEC. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. Lyon: International agency for Research on Cancer Press, 2004:57-103.
8. Asioli S, Erickson LA, Sebo TJ, et al. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 2010;34:44-52.
9. Sobin LH, Wittekind CH. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 7th edn. New York: Wiley, 2010.
10. Miyauchi A. General rules for the description of thyroid cancer. The Japanese Society of Thyroid Surgery. 6th edn. Tokyo: JCLS, 2005.
11. Bai Y, Kakudo K, Nakamura M, et al. Loss of cellular polarity/ cohesiveness in the invasive front of papillary thyroid carcinoma and periostin expression. Cancer Lett 2009;281:188-95.
12. Tang W, Nakamura Y, Zuo H, et al. Differentiation, proliferation and retinoid receptor status of papillary carcinoma of the thyroid. Pathol Int 2003;53:204-13. (Pubitemid 36628227)
13. Buley ID, Gatter KC, Heryet A, et al. Expression of intermediate filament proteins in normal and diseased thyroid glands. J Clin Pathol 1987;40:136-42. (Pubitemid 17008162)
14. Kakudo K, Tang W, Ito Y, et al. Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. J Clin Pathol 2004;57:1041-6. (Pubitemid 39331353)
15. Liu Z, Bai Y, Li Y, et al. Non-solid type thyroid carcinoma: a case report of moderately differentiated adenocarcinoma of the thyroid. Pathol Int 2010;60:524-7.
16. Holzinger A, Dingle S, Bejarano PA, et al. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Hybridoma 1996;15:49-53. (Pubitemid 26079724)
17. Ros P, Rossi DL, Acebron A, et al. Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. Biochimie 1999;81:389-96.
18. Zhang P, Zuo H, Nakamura Y, et al. Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Pathol Int 2006;56:240-5.
19. Asioli S, Erickson LA, Lloyd RV. Solid cell nests in Hashimoto's thyroiditis sharing features with papillary thyroid microcarcinoma. Endocr Pathol 2009;20:197-203.
20. Xu J, Wang R, Xie ZH, et al. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 2006;66:1664-73. (Pubitemid 44646357)
21. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-73.
22. Fuchs IB, Lichtenegger W, Buehler H, et al. The prognostic significance of epithelial-mesenchymal transition in breast cancer. Anticancer Res 2002;22:3415-19. (Pubitemid 36070123)
23. Vasko V, Espinosa AV, Scouten W, et al. Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U S A 2007;104:2803-8. (Pubitemid 46327960)
24. Kudo Y, Kitajima S, Ogawa I, et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res 2004;10:5455-63. (Pubitemid 39100483)
25. Nakajima S, Doi R, Toyoda E, et al. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 2004;10:4125-33. (Pubitemid 38812492)
26. Ito Y, Miyauchi A, Kakudo K, et al. Prognostic significance of Ki-67 labeling index in papillary thyroid carcinoma. World J Surg 2010;34:3015-21.
27. Kakudo K, Bai Y, Katayama S, et al. Classification of follicular cell tumors of the thyroid gland: analysis involving Japanese patients from one institute. Pathol Int 2009;59:359-67.
28. Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 2007;31:1256-64. (Pubitemid 47207131)